BioFluidica Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Series B1
  • Latest Deal Amount
  • $8.98M
Latest Deal Amount
  • Investors
  • 2

BioFluidica General Information

Description

Developer of a diagnostic platform intended to detect circulating biomarkers in blood samples to diagnose cancer with unprecedented precision and accuracy. The company's platform precisely captures and isolates disease biomarkers, such as circulating tumor cells and has been clinically validated, enabling physicians to detect cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Primary Office
  • Core Screening Facility Number1, 11575 Sorrento Valley Road
  • Suite 210
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

BioFluidica Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioFluidica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B1) 29-Mar-2021 $8.98M 000.00 0000 Completed Generating Revenue
9. Debt - PPP 28-Apr-2020 00.000 Completed Generating Revenue
8. Grant 10-Jan-2019 00.00 00.000 Completed Generating Revenue
7. Later Stage VC (Series B) 21-Jul-2017 000 00.000 000.00 Completed Generating Revenue
6. Grant 01-Jan-2017 00000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 24-May-2016 000 00.000 000 Completed Generating Revenue
4. Debt - General 04-Dec-2015 00000 00000 Completed Startup
3. Grant 24-Sep-2015 00.000 Completed Startup
2. Grant 01-Jan-2013 $1000K Completed Startup
1. Grant 01-Jan-2010 $200K Completed Startup
To view BioFluidica’s complete valuation and funding history, request access »

BioFluidica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1-C 0,000,000 00.00 00.00 00 00.00 00.00
Series B1 0,000,000 00.00 00.00 00 00.00 0.000
Series B 6,000,000 $0.85 $0.85 1x $0.85 21.79%
Series A 3,500,000 $0.58 $0.58 1x $0.58 12.71%
To view BioFluidica’s complete cap table history, request access »

BioFluidica Executive Team (4)

Name Title Board Seat Contact Info
Rolf Muller Ph.D Chief Executive Officer & Board Member
Judy Muller-Cohn Ph.D Chief Operating Officer
Steven Soper Ph.D Co-Founder, Chief Technology Officer & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

BioFluidica Board Members (5)

Name Representing Role Since
Michael Stocum BioFluidica Board Member 000 0000
Philip Buchanan Ph.D Self Board Member 000 0000
Rolf Muller Ph.D BioFluidica Chief Executive Officer & Board Member 000 0000
Sam Tetlow Self Chairman 000 0000
Steven Soper Ph.D BioFluidica Co-Founder, Chief Technology Officer & Board Member 000 0000
To view BioFluidica’s complete board members history, request access »

BioFluidica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioFluidica Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view BioFluidica’s complete investors history, request access »